Literature DB >> 7964607

Inhibition of protein synthesis by the human immunodeficiency virus type 1 nef gene product.

L Poulin1, M Fauchon, A Darveau, J A Levy.   

Abstract

During productive infection of human T lymphocytes in cell culture, the expression of human immunodeficiency virus type 1 is temporally regulated by virus-encoded regulatory proteins. Among these Nef, whose function has not been clearly elucidated, is thought to alter CD4+ T cells. We examined the possibility that the nef gene interferes with the translation process in a cell-free system. The results demonstrate that the nef gene product mediates an inhibitory effect on protein synthesis. Conversely, the use of antisense nef mRNA did not affect translation. Further observations suggest that this inhibitory effect is an inherent property of the nef gene product itself and not of its mRNA. The data show that the translational repression directed by Nef is a general phenomenon, acting on its own and on other messengers used as reporter mRNAs. We propose that, as a consequence, Nef can play an important role in the pathogenesis of AIDS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964607     DOI: 10.1099/0022-1317-75-11-2977

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Evolution of bacteriophage in continuous culture: a model system to test antiviral gene therapies for the emergence of phage escape mutants.

Authors:  Björn F Lindemann; Christian Klug; Andreas Schwienhorst
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus.

Authors:  B N Lee; J G Lu; M W Kline; M Paul; M Doyle; C Kozinetz; W T Shearer; J M Reuben
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

3.  Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics.

Authors:  T Luo; S J Anderson; J V Garcia
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.